Synopsys Has Lost 34% in a Year. Is the Selloff a Buying Opportunity?

Key Stats for Synopsys Stock

• Current Price: $415.99
• Target Price (Mid): ~$759
• Street Target: ~$564
• Potential Total Return: ~83%
• Annualized IRR: ~15% / year

Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>

What Happened?

Synopsys (SNPS) has lost roughly a third of its value over the past year, and the stock now changes hands near $416, down about 34% from twelve months ago and about 35% below its July 2025 peak. The chip design software maker didn’t stumble on its numbers. It beat estimates in fiscal Q2 and raised its full-year outlook. Yet the shares kept sliding into August, and the market’s worry has a name: the high-margin Design IP business, where revenue fell about 6% year over year last quarter.

That leaves investors a real question ahead of the August 26 earnings print. Synopsys makes tools that sit under nearly every advanced chip on earth, and it now trades at its cheapest forward multiple in recent memory, right as AI is supposed to be its biggest tailwind. Either the selloff handed patient buyers a rare discount, or the IP softness is telling something the beats are hiding.

The Cheapest SNPS Has Looked in Years, and the IP Business Is Why

Synopsys trades at about 26 times next-twelve-month earnings and roughly 20 times NTM EV/EBITDA. A year ago, the trailing P/E ratio sat above 70. That multiple compressed hard, and it did so while revenue grew. That is the shape of a de-rating, not a broken business.

The pressure traces to Design IP. That segment brought in about $454 million in fiscal Q2, down roughly 6% from a year earlier, and it carries some of the company’s richest margins. When the richest-margin piece shrinks, the whole story wobbles, even as total revenue jumps 42% to $2.276 billion. Management says the IP trough bottomed in fiscal Q1 and that Q2 delivered the sequential improvement it had promised. The direction is right, but the market wants a second clean quarter before it believes the turn. Synopsys still lifted full-year revenue guidance to roughly $9.67 billion at the midpoint, so the debate is not whether it is growing. It is whether the highest-quality growth is coming back.

See historical and forward estimates for Synopsys stock (It’s free!) >>>

Why the AI Story Got Louder Before the Print

While the stock drifted lower through July, the operating news got busier. At the DAC Chips to Systems Conference in late July, Synopsys announced a run of AI design collaborations that speak to its long-term thesis. It rolled out autonomous agentic workflows built with Nvidia technology, introduced new agentic EDA workflows developed with Microsoft and used by AMD, and extended its Intel Foundry work with certified AI-powered flows on Intel’s 14A process. One debug workflow showed up to a 40% cut in cycle time in early results. These are collaborations and evaluations, not signed revenue yet, and that distinction matters.

They also map onto how CEO Sassine Ghazi describes the next monetization layer. At the Mizuho Technology Conference on June 9, 2026, he explained that the industry’s two-decade shift to subscription licensing for human engineers is about to gain a second stream: “There will be another layer, which is consumption of agent use of the software.” In other words, agentic tools like the ones shown at DAC are meant to be billed on top of existing seats, not to cannibalize them. That is the revenue engine the market is currently discounting.

Ghazi was also direct about the Intel relationship that has drawn investor doubt: “You cannot be in the foundry business without Synopsys.” The Intel 14A certification gives that claim a concrete data point, right as Intel’s foundry ambitions face their own scrutiny. That matters because much of the bear case rests on customer concentration risk management insists is misread.

The peer comparison sharpens it. Cadence Design Systems trades near 40 times NTM earnings and about 29 times NTM EV/EBITDA, well above Synopsys at roughly 26 and 20 times. Two dominant players split the EDA market, and investors are paying a clear premium for the one without a visible IP wobble. Whether Synopsys deserves that discount is what the next print starts to answer.

See how Synopsys performs against its peers in TIKR (It’s free!) >>>

TIKR Advanced Model Analysis

• Current Price: $415.99
• Target Price (Mid): ~$759
• Potential Total Return: ~83%
• Annualized IRR: ~15% / year

See analysts’ growth forecasts and price targets for Synopsys stock (It’s free!) >>>

Two drivers carry that number. The first is revenue compounding around 11% a year in the mid case, powered by AI-driven chip complexity lifting EDA demand and the Ansys multiphysics platform opening a new simulation market to cross-sell. The second is the margin path: management targets mid-40s operating margins from about 41% today, helped by a 10% workforce reduction and $400 million in Ansys synergies pulled forward. Net income margin holds around 32% in the model.

The primary risk is the one the stock is already trading on. If Design IP fails to reaccelerate, or the royalty model Synopsys is negotiating with hyperscalers reaches the P&L slower than hoped, the growth mix stays lower-quality and the multiple has less reason to recover. The upside: IP inflects, agentic AI becomes a real second revenue layer, and the stock re-rates toward its peer. The downside: the IP trough proves stickier than management claims, and the discount to Cadence is deserved.

Conclusion

The number to watch on August 26 is Design IP. Management guided fiscal Q3 revenue to roughly $2.41 to $2.46 billion and adjusted EPS near $3.63 to $3.69, but the headline beat is not what decides this stock anymore. A second straight quarter of sequential IP growth, ideally with a firmer read on the royalty conversations, would confirm the trough held and hand the re-rating case its evidence. Flat or declining IP would validate the bears and keep the multiple where it is. The report lands after market close on August 26, and the September 30 Investor Day follows with management’s multi-year framework. Between those two dates, investors get the clearest look yet at whether this discount was an opportunity or a warning.

See what stocks billionaire investors are buying so you can follow the smart money with TIKR.

Should You Invest in Synopsys?

The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.

Pull up Synopsys, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.

You can build a free watchlist to track Synopsys alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.

Analyze Synopsys on TIKR Free →

Looking for New Opportunities?

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!